11 Nov 2010 Pevion's Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
10 Nov 2010 Diamyd Completes Screening for US Phase III Study
09 Nov 2010 Nabi Biopharmaceuticals Completes Enrollment of Second NicVAX Phase III Clinical Trial
08 Nov 2010 Advaxis Enters into Collaboration with the University of British Columbia
05 Nov 2010 New clinical study started with the nicotine vaccine NIC002
04 Nov 2010 Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
04 Nov 2010 Novel Recombinant Chikungunya Virus Vaccine Shown to be Safe and Effective in Multiple Animal Models
02 Nov 2010 Soligenix Announces Completion of Enrollment and Preliminary Safety Results of a Phase 1B Clinical Trial for RiVax
01 Nov 2010 Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine
01 Nov 2010 Phase 2b Study Demonstrates GlobeImmune's GI-5005 HCV Therapeutic Vaccine Increases Sustained Virologic Response by 12 Percent in Patients Who Previously Failed Therapy With Standard of Care
28 Oct 2010 Crucell N.V. (CRXL) Halts Vaccine Shipments to Investigate Plant
28 Oct 2010 GlobeImmune Expands GI-5005-02 Phase 2b Trial to Include Additional Treatment Naive IL28B T/T Subjects With Chronic Genotype 1 HCV
28 Oct 2010 ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration
25 Oct 2010 Phase III data show that Novartis meningococcal vaccine Menveo(R) demonstrated robust immunogenicity in infants
25 Oct 2010 Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
25 Oct 2010 Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine
25 Oct 2010 Positive Results From LigoCyte's Norovirus Vaccine Challenge Study Presented at IDSA Annual Meeting
25 Oct 2010 Inviragen Initiates DENVax Phase 1 Clinical Testing in Colombia
25 Oct 2010 Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
25 Oct 2010 Following Positive Phase II Data, Sanofi Pasteur to Conduct Phase III Trials of Quadrivalent Influenza Virus Vaccine
22 Oct 2010 European regulator backs nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
22 Oct 2010 Dynavax Technologies Corporation (DVAX)'s HEPLISAV Demonstrates Superior Seroprotection in Diabetics Compared to Engerix-B
22 Oct 2010 Novartis Phase III study indicates MF59(R) adjuvanted influenza vaccine, Fluad(R), is 75 percent more efficacious than studied non-adjuvanted vaccines in young children
21 Oct 2010 Advaxis Completes Recruitment of First 11 Patients in US Cervical Dysplasia Study
19 Oct 2010 MannKind Announces Initiation of Phase 2 Trial of Cancer Vaccine for Advanced Melanoma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up